Linked Life Data

10071172

Source:http://linkedlifedata.com/resource/pubmed/id/10071172

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1999-4-1
pubmed:abstractText
Anticardiolipin antibodies (aCL) have been recognized as a marker for an increased risk of thrombosis. There are no documented reports from India on the prevalence of aCL in patients with cerebral venous thrombosis (CVT). Our study aimed at establishing the prevalence of these antibodies in patients with CVT and evaluating their clinical significance.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0001-6314
pubmed:author
pubmed:issnType
Print
pubmed:volume
99
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
121-4
pubmed:dateRevised
2006-8-16
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Anticardiolipin antibodies: a study in cerebral venous thrombosis.
pubmed:affiliation
Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences, Bangalore, India.
pubmed:publicationType
Journal Article